IgG1 Kappa from Myeloma Serum

<strong>IgG1 Kappa from Myeloma Serum</strong>_x000D_ <strong>Catalog number:</strong> B2016910_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 0.5 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> Native Human IgG1 Kappa from Myeloma Serum_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Wypych J, Li M, Guo A, Zhang Z, Martinez T, Allen MJ, Fodor S, Kelner DN, Flynn GC, Liu YD, Bondarenko PV, Ricci MS, Dillon TM, Balland A. Human IgG2 antibodies display disulfide-mediated structural isoforms J Biol Chem. 2008 Jun 6;283(23):16194-205._x000D_ 2: Flatley EM, Segal GM, Batiuk TD, Bennett WM, Houghton DC, Troxell ML. Glomerular endothelial vesicles in a renal allograft: an unusual pattern of immunoglobulin deposition in a patient with biclonal gammopathy of unknown significance Am J Surg Pathol. 2015 Jun;39(6):864-9._x000D_ 3: Sheldon J, Wheeler RD, Powles R. Electrophoretic patterns post daratumumab Ann Clin Biochem. 2018 Mar;55(2):299-301._x000D_ 4: Nasr SH, Kudose S, Javaugue V, Harel S, Said SM, Pascal V, Stokes MB, Vrana JA, Dasari S, Theis JD, Osuchukwu GA, Sathick IJ, Das A, Kashkouli A, Suchin EJ, Liss Y, Suldan Z, Verine J, Arnulf B, Talbot A, Sethi S, Zaidan M, Goujon JM, Valeri AM, Mcphail ED, Sirac C, Leung N, Bridoux F, D'Agati VD. Pathological characteristics of light chain crystalline podocytopathy Kidney Int. 2023 Mar;103(3):616-626._x000D_ 5: Lyubimova NV, Timofeev YS, Abaev VM, Votyakova OM, Osmanov EA, Kushlinskii NE. Biochemical profile of Bence-Jones type multiple myeloma Klin Lab Diagn. 2022 Oct 14;67(10):570-574._x000D_ 6: Zhu AY, Zhu FB, Wang FC, Zhang LJ, Ma Y, Hu JG. [Analysis of Relationship between Serum Total Light Chain κ/λ Ratio and Proportion of Bone Marrow Plasma Cells in Patients with IgG type and IgA type Multiple Myeloma] Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Oct;25(5):1454-1459._x000D_ 7: Oriol R, Huerta J, Bouvet JP, Liacopoulos P. Two myeloma globulins, IgG1-kappa and IgG1-lambda, from a single patient (Im). I. Purification and immunochemical characterization Immunology. 1974 Dec;27(6):1081-93._x000D_ 8: Bergón E, Miravalles E, Bergón E, Miranda I, Bergón M. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma Clin Chem Lab Med. 2005;43(1):32-7._x000D_ 9: Bouvet JP, Buffe D, Oriol R, Liacopoulos P. Two myeloma globulins IgG1-kappa and IgG1-lambda, from a single patient (Im). II. Their common cellular origin as revealed by immunofluorescence studies Immunology. 1974 Dec;27(6):1095-101._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/3121749">10: Goñi F, Chuba J, Buxbaum J, Frangione B. A double monoclonal IgG1 kappa and IgG2 kappa in a single myeloma patient. Variation in clonal products and therapeutic responses J Immunol. 1988 Jan 15;140(2):551-7.</a>_x000D_ _x000D_ <strong>Products Related to IgG1 Kappa from Myeloma Serum can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>